Lataa...
Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients
Cutaneous melanoma is one of the highest incident‐rate cancers with increasing prevalence in Western societies. Despite the advent of new approved therapeutics, the 5‐year overall survival rate of stage IV melanoma patients remains below 15%. Current treatments for late stage disease have shown high...
Tallennettuna:
| Julkaisussa: | Mol Oncol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5307330/ https://ncbi.nlm.nih.gov/pubmed/26778792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2015.12.008 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|